Riefke B - Search Results

1

Characterization of a Novel Hafnium-Based X-ray Contrast Agent.

Frenzel T, Bauser M, Berger M, Hilger CS, Hegele-Hartung C, Jost G, Neis C, Hegetschweiler K, Riefke B, Suelzle D, Pietsch H. Frenzel T, et al. Among authors: riefke b. Invest Radiol. 2016 Dec;51(12):776-785. doi: 10.1097/RLI.0000000000000291. Invest Radiol. 2016. PMID: 27299578

2

Contrast media: future aspects.

Weinmann HJ, Platzek J, Schirmer H, Pietsch H, Carretero J, Harto J, Medina J, Riefke B, Martín J. Weinmann HJ, et al. Among authors: riefke b. Eur Radiol. 2005 Nov;15 Suppl 4:D70-3. doi: 10.1007/s10406-005-0119-4. Eur Radiol. 2005. PMID: 16479651 Review.

3

The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.

Steger-Hartmann T, Raschke M, Riefke B, Pietsch H, Sieber MA, Walter J. Steger-Hartmann T, et al. Among authors: riefke b. Exp Toxicol Pathol. 2009 Nov;61(6):537-52. doi: 10.1016/j.etp.2008.11.004. Epub 2009 Jan 7. Exp Toxicol Pathol. 2009. PMID: 19131226

4

Cyanine dyes as contrast agents in biomedical optical imaging.

Licha K, Riefke B, Ebert B, Grötzinger C. Licha K, et al. Among authors: riefke b. Acad Radiol. 2002 Aug;9 Suppl 2:S320-2. doi: 10.1016/s1076-6332(03)80216-7. Acad Radiol. 2002. PMID: 12188261 No abstract available.

5

Cyanine dyes as contrast agents for near-infrared imaging in vivo: acute tolerance, pharmacokinetics, and fluorescence imaging.

Ebert B, Riefke B, Sukowski U, Licha K. Ebert B, et al. Among authors: riefke b. J Biomed Opt. 2011 Jun;16(6):066003. doi: 10.1117/1.3585678. J Biomed Opt. 2011. PMID: 21721804 Free article.

6

Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization.

Licha K, Riefke B, Ntziachristos V, Becker A, Chance B, Semmler W. Licha K, et al. Among authors: riefke b. Photochem Photobiol. 2000 Sep;72(3):392-8. doi: 10.1562/0031-8655(2000)072<0392:hcdaca>2.0.co;2. Photochem Photobiol. 2000. PMID: 10989611

7

Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.

Pavkovic M, Riefke B, Gutberlet K, Raschke M, Ellinger-Ziegelbauer H. Pavkovic M, et al. Among authors: riefke b. J Pharmacol Toxicol Methods. 2014 Mar-Apr;69(2):196-204. doi: 10.1016/j.vascn.2013.11.003. Epub 2013 Dec 12. J Pharmacol Toxicol Methods. 2014. PMID: 24333954

8

Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury.

Pavkovic M, Riefke B, Ellinger-Ziegelbauer H. Pavkovic M, et al. Among authors: riefke b. Toxicology. 2014 Oct 3;324:147-57. doi: 10.1016/j.tox.2014.05.005. Epub 2014 May 28. Toxicology. 2014. PMID: 24880025

9

ICJ 3393: a new lodinated nonionic low osmolal dimer with low viscosity as contrast agent for X-ray.

Riefke B, González L, Carretero J, González C, Jimenéz I, Alguacil LF, Böhle F, Martin F, Martin JL. Riefke B, et al. Acad Radiol. 2002 May;9 Suppl 1:S178-81. doi: 10.1016/s1076-6332(03)80431-2. Acad Radiol. 2002. PMID: 12019862 No abstract available.

10

Oncogenes meet metabolism. From deregulated genes to a broader understanding of tumour physiology. Preface.

Riefke B, Mumberg D, Kroemer G, Keun H, Petersen K, Steger-Hartmann T. Riefke B, et al. Ernst Schering Found Symp Proc. 2007;(4):V-VII. Ernst Schering Found Symp Proc. 2007. PMID: 18811050 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page